Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Pulmonary Hypertension: Pharmacological and Non-Pharmacological Therapies

Version 1 : Received: 18 May 2024 / Approved: 20 May 2024 / Online: 20 May 2024 (12:16:29 CEST)

How to cite: Tsai, J.; Malik, S.; Tjen-A-Looi, S. C. Pulmonary Hypertension: Pharmacological and Non-Pharmacological Therapies. Preprints 2024, 2024051266. https://doi.org/10.20944/preprints202405.1266.v1 Tsai, J.; Malik, S.; Tjen-A-Looi, S. C. Pulmonary Hypertension: Pharmacological and Non-Pharmacological Therapies. Preprints 2024, 2024051266. https://doi.org/10.20944/preprints202405.1266.v1

Abstract

Pulmonary hypertension (PH) is a severe and chronic disease characterized by increased pulmonary vascular resistance and remodeling often precipitating right-sided heart dysfunction and death. Although the condition is progressive and incurable, current therapies for the disease focus on multiple different drugs and general supportive therapies to manage symptoms and prolong survival, ranging from medications more specific to pulmonary arterial hypertension (PAH) to exercise training. Moreover, there are multiple studies exploring novel experimental drugs and therapies including unique neurostimulation, to help better manage the disease. Here we provide a narrative review focusing on current PH treatments that target multiple underlying biochemical mechanisms, including but not limited to imbalances in vasoconstrictor-vasodilator and autonomic nervous system function, inflammation, and bone morphogenic protein (BMP) signaling. We also focus on the potential of novel therapies for managing PH, focusing on multiple types of neu-rostimulation including acupuncture. Lastly, we also touch upon the disease’s different subgroups, clinical presentations and prognosis, diagnostics, demographics, and cost.

Keywords

pulmonary hypertension (PH); pulmonary arterial hypertension (PAH); chronic thromboembolic pulmonary hypertension (CTEPH); cardiac dysfunction; neurostimulation and electroacupuncture; vascular remodeling; alveolar hypoxia

Subject

Medicine and Pharmacology, Pulmonary and Respiratory Medicine

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.